Jan 5, 2009 - BioSante Pharmaceuticals, Inc. announced that a new patent has issued covering Elestrin (estradiol gel), which is approved in the U.S. for moderate-to-severe vasomotor symptoms, known as hot flashes, associated with menopause. BioSante received approval of Elestrin from the U.S. FDA in December 2006.
The details can be read here.
No comments:
Post a Comment